Brunel International N.V. (0QUM)
London Exchange · UK · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 7.210 |
|---|---|
| 52-week range | 6.160 – 8.300 |
| Return, 1 month / 3 months | −0.1% / −3.4% |
| Return, 1 year / 3 years | −8.3% / −36.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 54 |
| Volatility (1 year) | 24.7% |
| Worst drawdown (1 year) | -24.7% |
| Average daily value traded | 0.03M EUR |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Brunel International is a Dutch provider of staffing and recruitment services based in Amsterdam. The company supplies skilled professionals, including engineers, information technology specialists and other technical staff, to clients in sectors such as energy, engineering and manufacturing. It works through specialist divisions and places people on temporary, project-based and permanent assignments, serving businesses in the Netherlands, Germany, the Middle East and other markets around the world.
On this site Brunel International N.V. appears as a stock on the London Exchange (UK), code 0QUM, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Brunel International N.V. (0QUM) trades on the London Exchange in UK. It last closed at EUR 7.210 on 22 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 2,157 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.3% and over the last three months it fell 3.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.3% | ||
| From 52-week high | -12.6% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.4% | ||
| 6-month return | 4.1% | ||
| 12-month return, skipping the last month | -8.2% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 24.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.7% | ||
| Liquidity | 20 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M EUR | ||
| Zero-volume days | 8.3% | ||
| Income | 27 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.3% |
|---|---|
| 1 month | −0.1% |
| 3 months | −3.4% |
| 6 months | +4.1% |
| 1 year | −8.3% |
| 3 years | −36.0% |
| 5 years | −19.3% |
Signals
| 50-day / 200-day average | 7.254 / 7.118 |
|---|---|
| Golden / death cross (60 days) | Golden, 37 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.448 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 May 2026 | EUR 0.0600 |
| 19 May 2025 | EUR 0.5500 |
| 20 May 2024 | EUR 0.5500 |
| 15 May 2023 | EUR 0.5500 |
| 23 May 2022 | EUR 0.4500 |
| 13 May 2021 | EUR 0.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.